MetaLabs (Korea) Performance
| 090370 Stock | 1,346 32.00 2.44% |
The company secures a Beta (Market Risk) of 0.0506, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MetaLabs' returns are expected to increase less than the market. However, during the bear market, the loss of holding MetaLabs is expected to be smaller as well. At this point, MetaLabs has a negative expected return of -0.27%. Please make sure to verify MetaLabs' total risk alpha, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk , to decide if MetaLabs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MetaLabs Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 3.3 B | |
| Total Cashflows From Investing Activities | -20.7 B |
MetaLabs |
MetaLabs Relative Risk vs. Return Landscape
If you would invest 160,000 in MetaLabs Co on August 28, 2024 and sell it today you would lose (25,400) from holding MetaLabs Co or give up 15.87% of portfolio value over 90 days. MetaLabs Co is generating negative expected returns and assumes 2.4694% volatility on return distribution over the 90 days horizon. Simply put, 21% of stocks are less volatile than MetaLabs, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MetaLabs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MetaLabs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MetaLabs Co, and traders can use it to determine the average amount a MetaLabs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1081
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 090370 |
Estimated Market Risk
| 2.47 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MetaLabs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MetaLabs by adding MetaLabs to a well-diversified portfolio.
MetaLabs Fundamentals Growth
MetaLabs Stock prices reflect investors' perceptions of the future prospects and financial health of MetaLabs, and MetaLabs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MetaLabs Stock performance.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.0071 | |||
| Profit Margin | (0.59) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | (25.55 B) | |||
| Shares Outstanding | 4.98 M | |||
| Price To Book | 0.19 X | |||
| Price To Sales | 0.38 X | |||
| Revenue | 39.3 B | |||
| EBITDA | (12.25 B) | |||
| Cash Flow From Operations | 2.28 B | |||
| Total Asset | 85.03 B | |||
About MetaLabs Performance
By analyzing MetaLabs' fundamental ratios, stakeholders can gain valuable insights into MetaLabs' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MetaLabs has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MetaLabs has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about MetaLabs performance evaluation
Checking the ongoing alerts about MetaLabs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MetaLabs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MetaLabs generated a negative expected return over the last 90 days | |
| The company reported the revenue of 39.3 B. Net Loss for the year was (14.51 B) with profit before overhead, payroll, taxes, and interest of 20.13 B. | |
| About 56.0% of the company shares are owned by insiders or employees |
- Analyzing MetaLabs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MetaLabs' stock is overvalued or undervalued compared to its peers.
- Examining MetaLabs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MetaLabs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of MetaLabs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MetaLabs' stock. These opinions can provide insight into MetaLabs' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MetaLabs Stock analysis
When running MetaLabs' price analysis, check to measure MetaLabs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetaLabs is operating at the current time. Most of MetaLabs' value examination focuses on studying past and present price action to predict the probability of MetaLabs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetaLabs' price. Additionally, you may evaluate how the addition of MetaLabs to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |